Results for the substance apalutamide

Apalutamide is a medication used in the treatment of advanced or metastatic prostate cancer that is androgen-dependent. It is an androgen receptor inhibitor that blocks the effects of androgens on tumor cells, thereby slowing the growth and spread of the cancer.

Apalutamide is administered orally in tablet form, usually once daily, as directed by a physician. It is often used in combination with other hormonal therapies to maximize treatment efficacy.

Common side effects include fatigue, skin rash, high blood pressure, and decreased bone density. In rare cases, seizures or other severe adverse reactions may occur, requiring careful medical monitoring.

Apalutamide is an important therapeutic option for patients with advanced prostate cancer, helping to extend survival and improve quality of life.